Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells - PubMed (original) (raw)

. 1995 Oct 1;155(7):3329-37.

Affiliations

PMID: 7561026

Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells

A M Cleary et al. J Immunol. 1995.

Abstract

The regulation of B cell death plays roles in the selection of Ag-specific B cells in humoral immune responses, controlling B cell homeostasis and perhaps limiting transformation. The present work addresses whether CD95 induces tonsillar B cells to undergo apoptosis and, if so, whether contact-dependent CD40-L:CD40 signaling can rescue tonsillar B cells from CD95-induced apoptosis. CD95 triggering by anti-CD95 mAb (APO-1) was studied in human tonsillar B cell populations that were separated by density centrifugation into fractions enriched for either low density, CD38+ B cells or high density, resting B cells. Low density tonsillar B cells express CD95 and undergo anti-CD95-mediated apoptosis by analysis of cellular morphology or DNA fragmentation by TUNEL assay. The induction of apoptosis in low density tonsillar B cells by anti-CD95 mAb is inhibited by CD40 signals provided by stably transfected CD40-L+ 293 cells, but not by control transfected 293 cells (expressing CD8). In addition, the rescuing effect of CD40-L+ cells is inhibited specifically by anti-CD40-L (mAb 5c8). The counteracting effects of CD95 and CD40 signaling were also studied in Ramos 2G6, a homogeneous B cell tumor line of germinal center phenotype that expresses CD95 and CD40. Similar to the behavior of low density tonsillar B cells, Ramos 2G6 undergoes anti-CD95-mediated apoptosis, which is prevented by CD40-mediated rescue. These data show that CD95 induces apoptosis in low density tonsillar B cells and that CD40-L:CD40 interactions rescue low density tonsillar B cells or the B cell tumor Ramos 2G6 from CD95-induced apoptosis, and suggest roles for CD95 and CD40 in B cell death and selection, respectively.

PubMed Disclaimer

Cited by

FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies.
Lang I, Zaitseva O, Wajant H. Lang I, et al. Int J Mol Sci. 2022 Oct 25;23(21):12869. doi: 10.3390/ijms232112869. Int J Mol Sci. 2022. PMID: 36361658 Free PMC article. Review.
RANTES and CD40L under Conditions of Long-Term Physical Exercise: A Potential Link to Adaptive Immunity.
Lenz M, Schönbauer R, Stojkovic S, Lee J, Gatterer C, Lichtenauer M, Paar V, Emich M, Fritzer-Szekeres M, Strametz-Juranek J, Graf S, Sponder M. Lenz M, et al. Int J Environ Res Public Health. 2022 Jul 16;19(14):8658. doi: 10.3390/ijerph19148658. Int J Environ Res Public Health. 2022. PMID: 35886510 Free PMC article.
A Novel Long Noncoding RNA lincRNA00892 Activates CD4+ T Cells in Systemic Lupus Erythematosus by Regulating CD40L.
Liu X, Lin J, Wu H, Wang Y, Xie L, Wu J, Qin H, Xu J. Liu X, et al. Front Pharmacol. 2021 Oct 11;12:733902. doi: 10.3389/fphar.2021.733902. eCollection 2021. Front Pharmacol. 2021. PMID: 34707498 Free PMC article.
Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling.
Smulski CR, Decossas M, Chekkat N, Beyrath J, Willen L, Guichard G, Lorenzetti R, Rizzi M, Eibel H, Schneider P, Fournel S. Smulski CR, et al. Cell Death Dis. 2017 Feb 9;8(2):e2601. doi: 10.1038/cddis.2017.22. Cell Death Dis. 2017. PMID: 28182009 Free PMC article.
The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells.
Koncz G, Hueber AO. Koncz G, et al. Front Immunol. 2012 Jul 25;3:207. doi: 10.3389/fimmu.2012.00207. eCollection 2012. Front Immunol. 2012. PMID: 22848207 Free PMC article.

Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells - PubMed (original) (raw)